海辰药业：公司2025年度报告已预约于2026年4月25日披露

Core Viewpoint - The company has scheduled the disclosure of its 2025 annual report for April 25, 2026, in response to an investor inquiry on the investor interaction platform [2] Group 1 - The company is 海辰药业 (Haitian Pharmaceutical) with stock code 300584.SZ [2] - The inquiry regarding the 2025 performance forecast was made by an investor on the interaction platform [2] - The scheduled date for the 2025 annual report disclosure is April 25, 2026 [2]